Literature DB >> 10897167

Valproic acid-induced hyperammonemic encephalopathy with triphasic waves.

A Kifune1, F Kubota, N Shibata, T Akata, S Kikuchi.   

Abstract

PURPOSE: To examine a patient with valproic acid (VPA)-induced hyperammonemic encephalopathy accompanied by triphasic waves.
METHODS: A 61-year-old male patient with epilepsy experienced disturbance of consciousness after VPA dose was increased because of poor seizure control. The electroencephalogram (EEG) taken on admission revealed triphasic waves and high-amplitude delta-activity with frontal predominance. Although serum hepatic enzymes, such as AST and ALT, were normal, serum ammonium level was high at 96 microg/dl (normal range, 3-47 microg/dl). Serum amino acid analysis showed multiple minor abnormalities. Administration of VPA was discontinued immediately after admission, while other anticonvulsants were continued.
RESULTS: The patient's condition was improved on the fourth day of admission. An EEG, serum ammonium level, and amino acid profile were normal on the eighth day. Based on VPA administration, serum ammonium levels, and results of amino acid analysis, this patient had VPA-induced hyperammonemic encephalopathy.
CONCLUSIONS: Our case indicates that caution is required if triphasic waves appear in VPA-induced hyperammonemic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10897167     DOI: 10.1111/j.1528-1157.2000.tb00263.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  7 in total

Review 1.  Drug-induced cerebellar ataxia: a systematic review.

Authors:  J van Gaalen; F G Kerstens; R P P W M Maas; L Härmark; B P C van de Warrenburg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

2.  Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.

Authors:  Neel Patel; Katherine B Landry; Rachel E Fargason; Badari Birur
Journal:  Psychopharmacol Bull       Date:  2017-01-26

Review 3.  Valproate-induced hyperammonemic encephalopathy.

Authors:  Alberto Verrotti; Daniela Trotta; Guido Morgese; Francesco Chiarelli
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

4.  Risk factors and outcome of hyperammonaemia in people with epilepsy.

Authors:  Umesh Vivekananda; Simona Balestrini; Angeliki Vakrinou; Elaine Murphy; Sanjay M Sisodiya
Journal:  J Neurol       Date:  2022-07-30       Impact factor: 6.682

5.  Valproate-associated hyperammonemic encephalopathy in subarachnoid hemorrhage: a diagnosis to consider.

Authors:  Vivian Fuellis; Pedro Grille; Federico Verga; Luis Urbán Alfaro; Lucciano Grasiuso; Marcelo Barbato
Journal:  Rev Bras Ter Intensiva       Date:  2022 Jan-Mar

6.  Valproic Acid-induced hyperammonemia in the elderly: a review of the literature.

Authors:  Vikrant Mittal; Sunanda Muralee; Rajesh R Tampi
Journal:  Case Rep Med       Date:  2009-08-19

7.  Risk factors of hyperammonemia in patients with epilepsy under valproic acid therapy.

Authors:  Yu-Lung Tseng; Chi-Ren Huang; Chih-Hsiang Lin; Yan-Ting Lu; Cheng-Hsien Lu; Nai-Ching Chen; Chiung-Chih Chang; Wen-Neng Chang; Yao-Chung Chuang
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.